Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Appointment Attendance in DM Patients
NCT ID: NCT03055702
Last Updated: 2017-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
270 participants
INTERVENTIONAL
2016-11-01
2018-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Automated SMS-Based Appointment Validation Tool
NCT01671189
Text Messaging and Cardiovascular Health in Diabetes Mellitus
NCT03724526
The Impact of a Video Cell Phone Reminder System on Glycemic Control in Patients With Diabetes Mellitus
NCT01075997
Mobile Motivation for Health Promotion Among Adolescents
NCT02504658
Text Message for Adolescents With Poorly Controlled Type 1 Diabetes
NCT02230137
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a single blind randomization study. It will be carried out in Ha Kwai Chung General Outpatient Clinic.
The primary outcome of this study is to evaluate the attendance rate of each individual doctor, nurses and allied health clinic appointments for diabetic patients, as well as their overall attendance rates:
1. Diabetes Complication Screening Clinic (OPAS DMCS/RDNA)
2. Diabetes Nurse Intervention Clinic (OPAS DMIC/RDNI)
3. DM nurse group (OPAS RDNG)
4. Dietitian Counselling (OPAS DC/DG)
5. Physiotherapy (OPAS PTC/PTG)
6. Diabetes Doctor Session (OPAS RDR)
7. Retino photo Assessment (OPAS RDO)
8. Blood taking appointment (OPAS LABT)
The secondary outcomes are:
* Acceptance Rate of SMS Reminder Vs Telephone Reminder Vs no reminder
* Factors associated with acceptance of SMS
1. Personal Parameters: Age, sex, educational level, occupation, mobile phone models, Habit of using mobile phone service
2. Disease Parameters: Number and types of comorbidity, disease control (by biochemical markers)
3. Quality of Life (by SF-6D)
* Reported adverse effects of the reminder system
* Chang in biochemical markers (BMI, HbA1c, LDL-c level) 6-9 months later
Subjects who agreed to participate in this study will first receive a survey on the acceptance of SMS service. For those agree to receive SMS reminder, they will be randomized to:
1. an SMS remind them to come for scheduled clinic appointment 24-72 hours before, or
2. usual care with no reminder / telephone reminder.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SMS group
receive a mobile phone text reminder for scheduled clinic appointment 24-72 hours before,
Mobile phone text message reminder
an SMS remind subjects to come for scheduled clinic appointment 24-72 hours before
Usual care group
Usual care, either telephone reminder or no reminder
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mobile phone text message reminder
an SMS remind subjects to come for scheduled clinic appointment 24-72 hours before
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have more than 1 clinic services appointment under RAMP-DM programme:
(e.g. blood taking, diabetic nurse individual counselling, group education, diabetic complication screening, retinal photo assessment, dietician counselling, etc)
Exclusion Criteria
2. Do not speak Cantonese/English or read Chinese/English
3. Mentally incapacitated
4. Pregnant Women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Authority, Hong Kong
OTHER_GOV
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Man Chi Dao, M.B.B.S.
Role: PRINCIPAL_INVESTIGATOR
Resident
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ha Kwai Chung General Outpatient Clinic
Kwai Chung, Hong Kong, Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KW/EX-16-104(100-10)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.